| scholarly article | Q13442814 |
| P2093 | author name string | Kuan-Pin Su | |
| P2860 | cites work | Meta-Analysis of the Effects of Eicosapentaenoic Acid (EPA) in Clinical Trials in Depression | Q22305455 |
| Antidepressant drug effects and depression severity: a patient-level meta-analysis | Q24598580 | ||
| Cytokines sing the blues: inflammation and the pathogenesis of depression | Q24633065 | ||
| Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis | Q24634019 | ||
| Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-PUFAs are related to major depression. | Q49152308 | ||
| Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. | Q50571918 | ||
| A randomized trial of paroxetine to prevent interferon-alpha-induced depression in patients with hepatitis C. | Q50574234 | ||
| A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. | Q50583478 | ||
| Advice to eat fish and mood: a randomised controlled trial in men with angina. | Q51029729 | ||
| Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. | Q51059710 | ||
| Omega-3 treatment of childhood depression: a controlled, double-blind pilot study. | Q55042041 | ||
| Major Depressive Disorder | Q56016676 | ||
| Safety of the Treatment of Interferon-Alpha-Induced Depression | Q58769838 | ||
| Manic episode associated with citalopram therapy for interferon-induced depression in a patient with chronic hepatitis C infection | Q60440987 | ||
| Omega-3 Fatty Acids for Secondary Prevention of Posttraumatic Stress Disorder After Accidental Injury | Q60644133 | ||
| Hypomania associated with omega3 fatty acids | Q73982747 | ||
| Are omega3 fatty acids beneficial in depression but not mania? | Q73982756 | ||
| Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double-blind randomised controlled trial | Q79701256 | ||
| Hepatitis C virus infection | Q27861002 | ||
| Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial | Q28143204 | ||
| Interferon-alpha-induced changes in tryptophan metabolism. relationship to depression and paroxetine treatment | Q28211825 | ||
| Safety considerations with omega-3 fatty acid therapy | Q28221131 | ||
| Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study | Q28239287 | ||
| Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry | Q28281056 | ||
| Microglia: active sensor and versatile effector cells in the normal and pathologic brain | Q29547240 | ||
| Retinopathy associated with high-dose interferon alfa-2b therapy | Q33337541 | ||
| A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers | Q33587452 | ||
| CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression | Q33751166 | ||
| Healthy intakes of n-3 and n-6 fatty acids: estimations considering worldwide diversity | Q33997646 | ||
| A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids | Q34005609 | ||
| Omega-3 for bipolar disorder: meta-analyses of use in mania and bipolar depression | Q34014195 | ||
| Elevated inflammation levels in depressed adults with a history of childhood maltreatment | Q34071255 | ||
| Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. | Q34096721 | ||
| Cytokine-induced sickness behaviour: mechanisms and implications | Q34114821 | ||
| Complementary and alternative medicine for major depressive disorder: a meta-analysis of patient characteristics, placebo-response rates, and treatment outcomes relative to standard antidepressants | Q34122407 | ||
| Hepatitis C infection, antiviral treatment and mental health: a European expert consensus statement | Q34293132 | ||
| Phospholipase A2 and cyclooxygenase 2 genes influence the risk of interferon-alpha-induced depression by regulating polyunsaturated fatty acids levels | Q34315488 | ||
| Anterior cingulate activation and error processing during interferon-alpha treatment | Q34350258 | ||
| Prophylactic antidepressant treatment in patients with hepatitis C on antiviral therapy: a double-blind, placebo-controlled trial | Q34365319 | ||
| Red cell membrane omega-3 fatty acids are decreased in nondepressed patients with social anxiety disorder | Q34461978 | ||
| Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids | Q34570179 | ||
| Effects of n-3 long-chain polyunsaturated fatty acids on depressed mood: systematic review of published trials | Q34589381 | ||
| Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder | Q34594598 | ||
| The macrophage theory of depression | Q34607619 | ||
| Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial | Q34616402 | ||
| Escitalopram for the prevention of peginterferon-α2a-associated depression in hepatitis C virus-infected patients without previous psychiatric disease: a randomized trial | Q34640432 | ||
| Docosahexaenoic Acid Suppresses Neuroinflammatory Responses and Induces Heme Oxygenase-1 Expression in BV-2 Microglia: Implications of Antidepressant Effects for Omega-3 Fatty Acids | Q34660464 | ||
| No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial | Q34705796 | ||
| Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial | Q35368296 | ||
| Childhood maltreatment predicts adult inflammation in a life-course study | Q35611661 | ||
| Viral hepatitis C. | Q35617324 | ||
| Discovering endophenotypes for major depression | Q35814986 | ||
| Omega-3 fatty acids upregulate adult neurogenesis. | Q35842841 | ||
| Are omega-3 fatty acids antidepressants or just mood-improving agents? The effect depends upon diagnosis, supplement preparation, and severity of depression | Q36417226 | ||
| Functional polymorphisms in the interleukin-6 and serotonin transporter genes, and depression and fatigue induced by interferon-alpha and ribavirin treatment | Q36442043 | ||
| Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. | Q36457583 | ||
| Candidate genes expression profile associated with antidepressants response in the GENDEP study: differentiating between baseline 'predictors' and longitudinal 'targets'. | Q36539999 | ||
| Omega-3 fatty acids and perinatal depression: a review of the literature and recommendations for future research | Q36576249 | ||
| Fluoxetine protects neurons against microglial activation-mediated neurotoxicity | Q36717735 | ||
| Expert opinion: omega-3 fatty acids and bleeding-cause for concern? | Q36763078 | ||
| Neuronal plasticity and antidepressant actions | Q36828335 | ||
| Mind-body interface: the role of n-3 fatty acids in psychoneuroimmunology, somatic presentation, and medical illness comorbidity of depression | Q37093283 | ||
| Activation of central nervous system inflammatory pathways by interferon-alpha: relationship to monoamines and depression | Q37126943 | ||
| Depression and hippocampal neurogenesis: a road to remission? | Q37131367 | ||
| Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials. | Q37349962 | ||
| Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'? | Q37384596 | ||
| Mechanisms of cell protection by heme oxygenase-1. | Q37670227 | ||
| A meta-analytic review of polyunsaturated fatty acid compositions in patients with depression | Q37746266 | ||
| Cytokines mediated inflammation and decreased neurogenesis in animal models of depression | Q37769871 | ||
| Depression and chronic medical illness | Q37928604 | ||
| Omega-3 polyunsaturated fatty acids for major depressive disorder | Q38148244 | ||
| Polyunsaturated fatty acids and their metabolites in brain function and disease. | Q38267176 | ||
| Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial | Q38391449 | ||
| Prophylactic treatment with escitalopram of pegylated interferon alfa-2a-induced depression in hepatitis C: a 12-week, randomized, double-blind, placebo-controlled trial | Q38498316 | ||
| Interferon-α induces nitric oxide synthase expression and haem oxygenase-1 down-regulation in microglia: implications of cellular mechanism of IFN-α-induced depression | Q39327912 | ||
| Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis | Q39445647 | ||
| Polyunsaturated fatty acid deficit in patients with bipolar mania | Q40598954 | ||
| Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial | Q42233349 | ||
| Randomised clinical trial: escitalopram for the prevention of psychiatric adverse events during treatment with peginterferon-alfa-2a and ribavirin for chronic hepatitis C. | Q43041286 | ||
| Paroxetine for the prevention of depression induced by high-dose interferon alfa | Q43556890 | ||
| Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. | Q43942974 | ||
| Inflammatory stimuli reduce survival of serotonergic neurons and induce neuronal expression of indoleamine 2,3-dioxygenase in rat dorsal raphe nucleus organotypic brain slices | Q44035277 | ||
| omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study | Q44265292 | ||
| Omega-3 fatty acids for depression in pregnancy | Q44299769 | ||
| Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. | Q44495175 | ||
| Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats | Q44709356 | ||
| Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats | Q44941884 | ||
| Lack of clinical therapeutic benefit of antidepressants is associated overall activation of the inflammatory system. | Q45958452 | ||
| A double-blind dose-finding pilot study of docosahexaenoic acid (DHA) for major depressive disorder. | Q46552016 | ||
| Omega-3 fatty acids are more beneficial in the depressive phase than in the manic phase in patients with bipolar I disorder. | Q46885747 | ||
| n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism | Q48418353 | ||
| Eicosapentaenoic acid appears to be the key omega-3 fatty acid component associated with efficacy in major depressive disorder: a critique of Bloch and Hannestad and updated meta-analysis | Q48701739 | ||
| (Neuro)inflammation and neuroprogression as new pathways and drug targets in depression: from antioxidants to kinase inhibitors. | Q48897316 | ||
| P433 | issue | 4 | |
| P921 | main subject | fatty acid | Q61476 |
| P304 | page(s) | 21 | |
| P577 | publication date | 2015-11-28 | |
| P1433 | published in | BioMedicine | Q27725996 |
| P1476 | title | Nutrition, psychoneuroimmunology and depression: the therapeutic implications of omega-3 fatty acids in interferon-α-induced depression | |
| P478 | volume | 5 |
| Q90327890 | Antidepressant-like Effects of p-Coumaric Acid on LPS-induced Depressive and Inflammatory Changes in Rats |
| Q52360936 | Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disorders. |
| Q47164633 | Head and neck cancer associated with increased rate of pulmonary tuberculosis in a population-based cohort study |
| Q41810459 | Kuei-Lu-Er-Xian-Jiao extract enhances BMP-2 production in osteoblasts |
| Q46780181 | Metformin Use Correlates with Reduced Risk of Gallstones in Diabetic Patients: A 12-Year Follow-up Study |
| Q38682777 | Statin use correlates with reduced risk of chronic osteomyelitis: a nationwide case-control study in Taiwan |
Search more.